CPT® Code 0477T

Deleted

1. Indications

The procedure of fetal magnetocardiography (FMCG) is indicated for various clinical scenarios during pregnancy. These include:

• Monitoring Fetal Well-Being The primary indication for FMCG is to monitor the overall well-being of the fetus, particularly during the second and third trimesters of pregnancy and during labor.
• Assessment of Fetal Movement FMCG is utilized to assess fetal movement, which is an important indicator of fetal health and activity.
• Evaluation of Heart Rate The procedure helps in evaluating the fetal heart rate, providing insights into the fetal cardiac function.
• Detection of Cardiac Arrhythmias FMCG is indicated for the detection of any potential cardiac arrhythmias that may affect the fetus.
• Identification of Congenital Cardiac Disease The technique is also used to identify congenital cardiac diseases, allowing for early intervention and management.

2. Procedure

The FMCG procedure involves several key steps to ensure accurate recording and analysis of fetal cardiac signals. These steps include:

• Electrode Placement Initially, a pair of electrodes is placed on the maternal abdomen to capture the fetal magnetic signals. A third electrode is then applied to the maternal chest to enhance the quality of the recordings.
• Signal Recording Once the electrodes are in place, the system begins recording the fetal magnetic cardiac signals. This process captures the small magnetic fields generated by the electrical activity of the fetal heart.
• Signal Extraction After recording, the signals are extracted from the collected data. This step is crucial for isolating the fetal cardiac signals from any maternal interference.
• Technical Analysis The extracted signals undergo a technical analysis, which involves evaluating the quality and characteristics of the fetal cardiac signals to ensure accurate interpretation.
• Result Compilation Finally, the results of the analysis are compiled, providing healthcare professionals with essential information regarding the fetal cardiac condition and overall well-being.

3. Post-Procedure

Post-procedure care following FMCG is generally minimal, as the procedure is non-invasive and does not typically require extensive recovery time. Patients may resume normal activities immediately after the procedure. However, healthcare providers may recommend monitoring for any unusual symptoms or changes in fetal movement following the test. The results of the FMCG will be reviewed and interpreted by a physician or qualified healthcare professional, who will discuss the findings with the patient and determine any necessary follow-up actions or interventions based on the results.